Leukemia Research
Volume 28, Issue 8 , Pages 831-844 , August 2004

Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression

  • Radovan Borojevic

      Affiliations

    • Hospital Universitário Clementino Fraga Filho and Departamento de Histologia e Embriologia, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil
    • ,
  • Rosimeire A Roela

      Affiliations

    • Disciplina de Oncologia, Departamento de Radiologia, Faculdade de Medicina da Universidade de Sao Paulo (LIM-24), Av. Dr Arnaldo, 455-sala 4112, CEP 01246-903 Sao Paulo, Brazil
    • The authors have contributed equally to this study.
    • ,
  • Renato S Rodarte

      Affiliations

    • Hospital Universitário Clementino Fraga Filho and Departamento de Histologia e Embriologia, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil
    • The authors have contributed equally to this study.
    • ,
  • Leandro S Thiago

      Affiliations

    • Hospital Universitário Clementino Fraga Filho and Departamento de Histologia e Embriologia, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil
    • ,
  • Fátima S Pasini

      Affiliations

    • Disciplina de Oncologia, Departamento de Radiologia, Faculdade de Medicina da Universidade de Sao Paulo (LIM-24), Av. Dr Arnaldo, 455-sala 4112, CEP 01246-903 Sao Paulo, Brazil
    • ,
  • Fabiana M Conti

      Affiliations

    • Hospital Universitário Clementino Fraga Filho and Departamento de Histologia e Embriologia, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil
    • ,
  • Maria Isabel D Rossi

      Affiliations

    • Hospital Universitário Clementino Fraga Filho and Departamento de Histologia e Embriologia, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil
    • ,
  • Luiz F.L Reis

      Affiliations

    • Instituto Ludwig, São Paulo, Brazil
    • ,
  • Luiz F Lopes

      Affiliations

    • Departamento de Pediatria do Hospital do Câncer A.C. Camargo, Brazil
    • ,
  • M.Mitzi Brentani

      Affiliations

    • Disciplina de Oncologia, Departamento de Radiologia, Faculdade de Medicina da Universidade de Sao Paulo (LIM-24), Av. Dr Arnaldo, 455-sala 4112, CEP 01246-903 Sao Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55-11-30667488; fax: +55-11-30826580.

Received 8 September 2003 ,Accepted 24 November 2003.

References 

  1. Mecucci C. Molecular features of primary MDS with cytogenetic changes. Leuk. Res. 1998;22:293–302
  2. Willman CL. Molecular genetic features of myelodysplastic syndromes (MDS). Leukemia. 1998;12(1):2–6
  3. Koeffler HP. Myelodysplastic syndrome (preleukemia). Sem. Haematol. 1986;23:284–299
  4. Borbenyi Z, Cinkotai C, Harrison C, Testa NG. The growth of myelodysplastic bone marrow in long-term cultures. Br. J. Cancer. 1987;55:291–293
  5. Coutinho LH, Geary CG, Chang J, Harrison C, Testa NG. Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS). Br. J. Haematol. 1990;75:16–25
  6. Aizawa S, Nakano M, Iwase O, Yaguchi M, Hiramoto M, Hoshi H, et al.  Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro. Leuk. Res. 1999;23:239–246
  7. Alvi S, Shaher A, Shetty V, Henderson B, Dangerfield B, Zorat F, et al.  Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic Syndromes. Leuk. Res. 2001;25:941–954
  8. Wetzler M, Kurzrock R, Estrov Z, Estey E, Talpaz M. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leuk. Res. 1995;19:23–34
  9. Kouides PA, Bennett JM. Understanding the myelodysplastic syndromes. Oncologist. 1997;2:389–401
  10. Flores-Figueroa E, Gutiérrez-Espı́ndola G, Montesinos JJ, Arana-Trejo RM, Mayani H. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk. Res. 2002;26:677–686
  11. Lambertenghi Deliliers GH, Annaloro C, Soligo D, Oriani A. The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes. Leuk. Lymphoma. 1998;28:231–239
  12. Duhrsen U, Hossfeld DK. Stromal abnormalities in neoplastic bone marrow diseases. Ann. Hematol. 1996;73:53–70
  13. Rigolin GM, Cuneo A, Roberti MG, Castoldi G. Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization. Haematologica. 1997;82:25–30
  14. Aricó M, Biondi A, Pui CH. Juvenile myelomonocytic leukemia. Blood. 1997;90:479–488
  15. Cambier N, Baruchel A, Schlageter MH, Menot ML, Wattel E, Fenaux P, et al.  Chronic myelomonocytic leukemia: from biology to therapy. Hematol. Cell Ther. 1997;39:41–48
  16. Sasaki H, Manabe A, Kojima S, Hayashi Y, Ikuta K, Okamura J, et al.  Myelodysplastic syndrome on childhood: a retrospective study of 189 patients in Japan. Leukemia. 2001;15:1713–1720
  17. Lopes LF, Lorand-Metze I, Niero-Melo L, Tone LG, Velloso E, Campanaro CM, et al.  The Brazilian Pediatric Myelodysplastic Cooperative Group strategies: are they relevant to improve educational approach and correct diagnosis?. Leuk. Res. 2002;26(7):637–642
  18. Collins LS, Dorshkind K. A stromal cell line from myeloid long-term bone marrow culture can support myelopoiesis and B lymphopoiesis. J. Immunol. 1987;138:1082–1087
  19. Margis R, Borojevic R. Quantification of attached cells in tissue culture plates and on microcarriers. Anal Biochem. 1989;181:209–211
  20. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992;257:967–971
  21. de Souza SJ, Camargo AA, Briones MR, Costa FF, Nagai MA, Verjovski-Almeida S, et al.  Identification of human chromosome 22 transcribed sequences with ORF expressed sequence tags. Proc. Natl. Acad. Sci. U.S.A. 2000;97(23):12690–12693
  22. Meireles SI, Carvalho AF, Hirata R, Montagnini AL, Martins WK, Runza FB, et al.  Differentially expressed genes in gastric tumors identified by cDNA array. Cancer Lett. 2003;190(2):199–211
  23. Kumazaki T, Mitsui Y, Hamada K, Sumida H, Nishiyama M. Detection of alternative splicing of fibronectin mRNA in a single cell. J. Cell. Sci. 1999;112:1449–1453
  24. Siler U, Seiffert M, Puch S, Richards A, Torok-Storb B, Muller CA, et al.  Characterization and functional analysis of laminin isoforms in human bone marrow. Blood. 2000;96:4194–4203
  25. Dennis JF, Charbord P. Differentiation of human and murine stroma. Stem Cells. 2002;20:205–214
  26. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al.  Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982;5:189–199
  27. Raza A. Hypothesis: myelodysplastic syndromes may have viral etiology. Int. J. Hematol. 1998;68:245–256
  28. Mundle S, Allampallam K, Rashid KA, Dangerfield B, Cartlidge J, Zeiter D, et al.  Presence of activation-related mRNA for EBV and CMV in the bone marrow of patients with myelodysplastic syndromes. Cancer Lett. 2001;164:197–205
  29. Raza A, Gregory SA, Preisler HD. The myelodysplastic syndromes in 1996: complex stem cell disorders confounded by dual actions of cytokines. Leuk. Res. 1996;20:881–890
  30. Yoshida Y, Mufti GJ. Apoptosis and its significance in MDS: controversies revisited. Leuk. Res. 1999;23:777–785
  31. Winter SS, Hanissian GA, Harville TO, Ware RE. Tumor necrosis factor-α suppressed hematopoiesis in children with Myelodysplasia. Med. Am. Ped. Oncol. 1997;28:69–74
  32. Dieudonne SC, Kerr JM, Xu T, Sommer B, DeRubeis AR, Kuznetsov SA, et al.  Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone. J. Cell. Biochem. 1999;76(2):231–243
  33. Taichman RS, Emerson SG. The role of osteoblasts in the hematopoietic microenvironment. Stem Cells. 1998;16(1):7–15
  34. Visnjic D, Kalajzic T, Gronowicz G, Aguila HL, Clark SH, Lichtler AC, et al.  Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J. Bone Miner. Res. 2001;16:2222–2231
  35. Benito AI, Bryant E, Loken MR, Sale GE, Nash RA, Gass MJ, et al.  NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors. Leuk. Res. 2003;27:425–436
  36. Yan Q, Sage EH. SPARC, a matricellular glycoprotein with important biological functions. J. Histochem. Cytochem. 1999;47(12):1495–1506
  37. Sturm RA, Satyamoorthy K, Meier F, Gardiner BB, Smith DJ, Vaidya B, et al.  Osteonectin/SPARC induction by ectopic β3 integrin in human radial growth phase primary melanoma cells. Cancer Res. 2002;62:226–232
  38. Lewis JM, Truong TN, Schwartz MA. Integrins regulate the apoptotic response to DNA damage through the modulation of p53. Proc. Natl. Acad. Sci. U.S.A. 2002;99:3627–3632
  39. Gupta P, Oegema TR, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of multimolecular stem cell niches. Blood. 1998;92(12):4641–4651

PII: S0145-2126(03)00415-6

doi: 10.1016/j.leukres.2003.11.019

Leukemia Research
Volume 28, Issue 8 , Pages 831-844 , August 2004

Article Tools

* Image Usage & Resolution